Pembrolizumab-induced myasthenia gravis: Two patients’ experiences
Checkpoint inhibitors are increasingly used to treat patients with gynecologic malignancies and can cause rare and unusual side effects, also known as immunotoxicities, that are rarely observed in patients receiving traditional immunotherapy. If these are not identified and treated, they can cause d...
Salvato in:
| Autori principali: | , , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Elsevier
2024-08-01
|
| Serie: | Gynecologic Oncology Reports |
| Soggetti: | |
| Accesso online: | http://www.sciencedirect.com/science/article/pii/S2352578924001322 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|